|Home||Company Search||Related Articles||Forum (new!)|
|Company||GlaxoSmithKline [Company Info]|
|Track this Company (an email will be sent to you everytime a report is filed about this company)|
|6th Sep 2004||Other Issue||GSK faces anti-depressant lawsuit|
|GlaxoSmithKline (GSK) is facing a US lawsuit alleging that it covered up negative research findings on its anti-depressant drug Paxil.
The lawsuits were filed on behalf of children and teenagers who were prescribed Paxil, known as Seroxat in the UK and Europe.
They claim GSK suppressed data showing that Paxil increased suicidal tendencies in young people.
GSK has denied the allegations, and said it would defend itself in court.
The lawsuit is the latest in series of legal battles GSK has had to fight over Paxil, once its best-selling drug.
Earlier this year, claims that some research into Paxil may have been withheld triggered an investigation by New York prosecutor Eliot Spitzer.
Last month, the company paid $2.5m (£1.3m) to settle Mr Spitzer's inquiry.
It also agreed to publish the results of all clinical tests on its drugs since December 2000 on the internet.
The December cut-off date marks the point at which Glaxo Wellcome merged with Smithkline Beecham.
GSK is also fighting separate lawsuits brought by adult Paxil users who claim it caused adverse side-effects.
GSK shares were down 4 pence at £11.49 in early afternoon trade in London.
|Other Reports on GlaxoSmithKline|
|29th Jan 2007||Questionable Practice||GlaxoSmithKline||GSK hid paxil suicide link|
|10th Aug 2006||Other Issue||GlaxoSmithKline||Glaxo pays $70m to end price row|
|29th Mar 2006||Questionable Practice||GlaxoSmithKline||Glaxo agrees US Paxil settlement|
|18th Mar 2005||Other Issue||GlaxoSmithKline||Glaxo shares dip on factory probe|
|22nd Sep 2004||Questionable Practice||GlaxoSmithKline||Glaxo drops appeal in Aids drug pricing case|
|19th May 2004||Other Issue||GlaxoSmithKline||New York sues GlaxoSmithKline|
|11th May 2004||Fraud Investigation||GlaxoSmithKline||GlaxoSmithKline faces antitrust investigation|
|22nd Jan 2004||Fraud Investigation||GlaxoSmithKline||$11.1 Million settlement|
|8th Jan 2004||Questionable Practice||GlaxoSmithKline||£1.5bn Tax Bill|
|16th Dec 2003||Questionable Practice||GlaxoSmithKline||Glaxo's CEO to scoop 5.7 mln stg a year|
|25th Jun 2003||Questionable Practice||GlaxoSmithKline||FDA tells Glaxo to pull misleading Flonase ads|
|25th Jun 2003||Questionable Practice||GlaxoSmithKline||Ordered to pull misleading adverts|
|Related Reports from the Pharamaceutical Industry|
|Pfizer||Other Issue||Watchdog probes drug distribution|
|Merck||Other Issue||Vioxx court case ends in mistrial|
|AstraZeneca||Fraud Investigation||Fined for Medicaid Fraud|
|AstraZeneca||Fraud Investigation||$355m fraud fine|
|Merck||Other Issue||Merck fined $9m in Vioxx lawsuit|
|© 2006 Corp-Ethics.com | Corporate Ethics|